Podcast

Bringing Together the Lung Cancer Community

Author(s):

Kristie L. Kahl

In this episode of the “CURE Talks Cancer” podcast, we looked back on CURE’s Lung Cancer Heroes event and recognized each winner that helps bring together the lung cancer community to raise awareness.

On October 15th, CURE® recognized five individuals for their contributions to the lung cancer space and raising awareness to end the stigma, inform, connect, and empower anyone who has been impacted by lung cancer.

During the inaugural virtual event, four individuals — two physicians, a nurse and a patient turned advocate — were awarded for their contributions to the lung cancer community. The program also recognized one Lifetime Achievement award winner.

lung cancer, Takeda, heroes, patients, community

In this episode of the “CURE Talks Cancer” podcast, we spoke with Bonnie J. Addario, Carolyn Baggett, Dr. Jennifer Garst, Dr. Fred Hirsh and Deborah Pickworth about their contributions and why bringing the lung cancer community is vital in raising awareness around the disease.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of a man in a suit.
Image of man with black hair.
Image of man with gray hair.
Image of Dr. Minesh Mehta at ASCO 2024.
Related Content
"FDA" text.
Published: December 18th 2024 | Updated: December 19th 2024

FDA Approves Ensacove for ALK-Positive NSCLC

Alex Biese
The Food and Drug Administration has approved Ensacove for patients with ALK-positive locally advanced or metastatic non-small cell lung cancer who have not previously received an ALK-inhibitor.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
"FDA" text.
December 5th 2024

FDA OKs Imfinzi for Limited-Stage Small Cell Lung Cancer

Darlene Dobkowski, MA
Imfinzi was approved by the FDA for the treatment of adults with limited-stage small cell lung cancer without disease progression after chemotherapy and radiation.
cancer horizons podcast logo: a white microphone on a blue background
March 4th 2024

Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

Alex Biese Brielle Benyon
In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Image of FDA Breakthrough Therapy Designation on a gold background.
December 3rd 2024

FDA Grants Breakthrough Therapy Designation to Sac-TMT for Some with NSCLC

Alex Biese
The FDA has granted Breakthrough Therapy designation to sacituzumab tirumotecan for patients with advanced or metastatic nonsquamous NSCLC with EGFR mutations.
Illustration of a person holding a magnifying glass next to paperwork and pills.
December 3rd 2024

Nemvaleukin Shows Manageable Safety Profile in Advanced Solid Tumors

Ashley Chan
In patients with advanced solid tumors, treatment with nemvaleukin with or without Keytruda demonstrated antitumor activity and tolerability.